Lawrence Blatt insider trades

Open-market stock purchases and sales by Lawrence Blatt, President and CEO at Aligos Therapeutics, Inc, from SEC Form 4 filings since Oct 20, 2020.

Recent trades

DateStockTradeValue
Mar 9, 2026ALGS Aligos Therapeutics, IncBought (not open market)—

Companies traded

  • ALGS Aligos Therapeutics, Inc: other filings, last Mar 9, 2026

Get free alerts when Lawrence Blatt files a new trade →